Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-04 4:30 pm Sale | 2025-12-02 | 13D | NewAmsterdam Pharma Company N.V. NAMS | BCLS II Investco, LP | 5,376,356 4.700% | -6,046,148 (-52.93%) | Filing History |
| 2025-11-07 7:19 pm Purchase | 2025-11-05 | 13D | NewAmsterdam Pharma Company N.V. NAMS | BCLS II Investco, LP | 11,422,504 9.990% | 11,422,504 (New Position) | Filing History |
| 2024-12-17 5:35 pm Unchanged | 2024-12-17 | 13D | NewAmsterdam Pharma Company N.V. NAMS | BCLS II Investco, LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-03-01 4:30 pm Unchanged | 2024-03-01 | 13D | NewAmsterdam Pharma Company N.V. NAMS | BCLS II Investco, LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-06-13 5:04 pm Unchanged | 2023-06-13 | 13D | NewAmsterdam Pharma Company N.V. NAMS | BCLS II Investco, LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-12-02 4:24 pm Unchanged | 2022-12-02 | 13D | NewAmsterdam Pharma Company N.V. NAMS | BCLS II Investco, LP | 0 0.000% | 0 (Unchanged) | Filing |